Savient Shares Rally As FDA Approves Gout Drug

September 15, 2010

130

Shares of Savient Pharmaceuticals Inc. jumped 27%, a day after the company’s gout drug Krystexxa got U.S. regulatory approval making it the first approved treatment for gout in adults who do not improve with conventional therapies.

*For more on this story, read the full Reuters article.

Want more from the best local business newspaper in the country?

Sign-up for our FREE Daily eNews update to get the latest Orange County news delivered right to your inbox!

Would you like to subscribe to Orange County Business Journal?

One-Year for Only $99

Unlimited access to OCBJ.com
Daily OCBJ Updates delivered via email each weekday morning
Journal issues in both print and digital format
The annual Book of Lists: industry of Orange County's leading companies
Special Features: OC's Wealthiest, OC 500, Best Places to Work, Charity Event Guide, and many more!

Hyundai Expanding Fountain Valley Headquarters

Industrial Production Rises 0.2% in August

staff-author

Savient Shares Rally As FDA Approves Gout Drug

Want more from the best local business newspaper in the country?

Would you like to subscribe to Orange County Business Journal?

Featured Articles

PHOTOS: More About Almond Surfboards

A Look at Chipotle Mexican Grill’s Brand History

Inside the $10M Sale of a Spanish Coastal Home in Lido Isle

Related Articles

PHOTOS: More About Almond Surfboards

A Look at Chipotle Mexican Grill’s Brand History

Inside the $10M Sale of a Spanish Coastal Home in Lido Isle

OC Unemployment Falls to 3.8% in March

Irvine Real Estate Firm Buys Luxury Hollywood Towers

Advertise With Us

About Us

Subscriber Links

Other Journals